Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_assertion type Assertion NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_head.
- NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_assertion description "[We describe treatment of a refractory, progressive Li-Fraumeni syndrome embryonal carcinoma with a p53 therapy (Advexin) targeted to the underlying molecular defect of this syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_provenance.
- NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_assertion evidence source_evidence_literature NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_provenance.
- NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_assertion SIO_000772 17483435 NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_provenance.
- NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_assertion wasDerivedFrom befree-20140225 NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_provenance.
- NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_assertion wasGeneratedBy ECO_0000203 NP226811.RA8TXFTpF2n58QBRd5iyeoRoSSVBlYu7O5oFthjtp7GKs130_provenance.